As of 2026-03-16, the EV/EBITDA ratio of Intercept Pharmaceuticals Inc (ICPT) is -22.57. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ICPT's latest enterprise value is 915.51 mil USD. ICPT's TTM EBITDA according to its financial statements is -40.56 mil USD. Dividing these 2 quantities gives us the above ICPT EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 8.5x - 14.7x | 12.0x |
| Forward P/E multiples | 10.6x - 16.1x | 14.0x |
| Fair Price | (13.18) - (17.12) | (15.48) |
| Upside | -169.4% - -190.1% | -181.5% |
| Date | EV/EBITDA |